Oncolytics Biotech

ONCYNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$58.637 M

$0.45 +5.27%

Close of 6 Nov 2026

As of 6 Nov 2026, Oncolytics Biotech (ONCY) has a market capitalization of $58.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$28.8M

Loss-making

Shares outstanding

127,510,505

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#318Quantum CyberQUCY$60.6M
#319Spero TherapeuticsSPRO$59.3M
#320Oncolytics BiotechONCY$58.6M
#321Gossamer BioGOSS$57.9M
#322Telomir PharmaceuticalsTELO$57.5M

What if Oncolytics Biotech were worth as much as…

Open the what-if tool →

Gold $28.2T

$215,350.20

Per share 481,552× higher

Bitcoin $1.53T

$11,652.22

Per share 26,056× higher

Apple $5.02T

$38,253.17

Per share 85,539× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Oncolytics Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.